PROLANZA olanzapine 2.5mg tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Laadi alla Avaliku hindamisaruande (PAR)
28-11-2017

Toimeaine:

olanzapine, Quantity: 2.5 mg

Saadav alates:

Medis Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

Olanzapine

Ravimvorm:

Tablet, film coated

Koostis:

Excipient Ingredients: hyprolose; magnesium stearate; microcrystalline cellulose; crospovidone; lactose monohydrate; purified talc; titanium dioxide; xanthan gum; polyvinyl alcohol; lecithin

Manustamisviis:

Oral

Ühikuid pakis:

50, 40, 21, 14, 60, 28, 10, 30, 7, 20

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

For the treatment of schizophrenia and related psychoses. ,Alone or in combination with lithium or valproate, it is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. ,For preventing recurrence of manic, mixed or depressive episodes in Bipolar I Disorder.

Toote kokkuvõte:

Visual Identification: White, round, biconvex film coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Volitamisolek:

Registered

Loa andmise kuupäev:

2011-08-11